Blueberries Medical Corp. (CSE: BBM) shared its financial results for the quarter ended March 31, 2021. The company earned $23,120 in revenue for Q1 2021 and since it is in its early stages of commercial operations, there were no revenue numbers recorded during the comparable period last year.
The Colombia-based cannabis company recorded a $590,325 net loss for the quarter, compared to last year’s net loss of $1.7 million. The majority of this loss can be attributed to depreciation and amortization expenses, general and administrative expenses, and pre-operating expenses.
This quarter’s net loss translates to a $0.004 loss per share.
Blueberries Medical Corp. last traded at $0.095 on the CSE.
Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
